Use of mesna compounds to prevent adverse reactions to...

Details Use of mesna compounds to prevent adverse reactions to... Use of mesna compounds to prevent adverse reactions to...

A - Human Necessities

61

K

A61K 31/337 (2006.01) A61K 31/095 (2006.01) A61K 31/105 (2006.01) A61K 31/185 (2006.01) A61K 31/282 (2006.01) A61K 31/555 (2006.01) A61K 31/663 (2006.01) A61K 33/24 (2006.01)

Patent

CA 2434270

A method of treating patients with cancer that involves administration of a combination regimen of a platinum agent, a taxane agent, and a formula (I) toxicity-reducing agent. The preferred order of administration is the formula (I) compound, followed by the platinum complex, followed by the taxane agent.

L'invention concerne une méthode de traitement de patients souffrant de cancer, qui consiste à administrer un schéma posologique combiné d'un agent au platine, d'un agent au taxane et d'un agent réduisant la toxicité, de formule (I). L'ordre d'administration préféré est le suivant : composé de formule I, complexe platine et agent au taxane.

Affiliated with

Also associated with

Rating

Use of mesna compounds to prevent adverse reactions to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of mesna compounds to prevent adverse reactions to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mesna compounds to prevent adverse reactions to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2090264